Obesity is a chronic disease, and we need to treat it like one, says Sara Velayati, MD, an obesity medicine specialist at the Fleischer Institute Medical Weight Management Center at Montefiore Einstein in the Bronx, New York
Learn the key differences between them and how to decide which medication is right for you
This approach provides growth hormone benefits alongside proven weight loss compounds
GLP-3R peptide is studied in laboratory environments for its interaction with multiple receptor pathways and its role in coordinated signaling systems
Winner for energy expenditure: Survodutide (glucagon-mediated thermogenesis is unique to this mechanism)
Immediate consultation is warranted if you develop: Rapid weight gain accompanied by swelling, shortness of breath, or decreased urine output (possible fluid retention or heart failure) Return of obesity-related complications such as uncontrolled blood pressure, worsening diabetes control (elevated blood glucose readings), or sleep apnea symptoms Severe increase in appetite that interferes with daily functioning or leads to binge eating episodes Psychological distress, depression, or anxiety related to weight changes Severe abdominal pain, especially radiating to the back, with or without vomiting (possible pancreatitis) Right upper quadrant abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Gastrointestinal symptoms that persist after stopping Zepbound Follow-up schedule should be tailored to your individual risk factors and comorbidities
